Header Logo

Connection

NICOLA HANANIA to Chemokine CCL17

Back to Details
This is a "connection" page, showing publications NICOLA HANANIA has written about Chemokine CCL17.
NICOLA HANANIA
Connection Strength
0.061
Chemokine CCL17
  1. Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2025 Aug; 13(8):687-697.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.